Article

Hypoxia-related radiomics predict immunotherapy response: A multi-cohort study of NSCLC

2020-04-04

Abstract excerpt

Checkpoint blockade immunotherapy provides improved long-term survival in a subset of advanced stage non-small cell lung cancer (NSCLC) patients. However, highly predictive biomarkers of immunotherapy response are unmet clinical need. In this study, we utilized pre-treatment clinical factors and quantitative image-based biomarkers (radiomics) to identify a parsimonious model that predicts survival outcomes among N...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9f81630d-bb7b-5bf0-bdbd-04cb863d74f6
DOI: 10.1101/2020.04.02.020859

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hypoxia-related radiomics predict immunotherapy response: A multi-cohort study of NSCLCDOI 10.1101/2020.04.02.020859Read

Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutationSemantic proximity Read

Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation.Semantic proximity Read

Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker.Semantic proximity Read

Integrated CT-derived radiomics for predicting ctDNA status and prognosis in resectable non-small cell lung cancerSemantic proximity Read

Predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma after third-generation TKI resistance using CT radiomics-based habitat imaging.Semantic proximity Read

Identifying transcription patterns of histology and radiomics features in NSCLC with neural networksSemantic proximity Read

Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after ChemoradiationSemantic proximity Read

Radiomicsmetabolic signature profiles for advanced non-small cell lung cancer with chemoimmunotherapy by reflecting biological function and survivalSemantic proximity Read

Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers.Semantic proximity Read

Integrating Radiomics with Genomics for Non-Small Cell Lung Cancer Survival AnalysisSemantic proximity Read

CT Radiomics-Clinical Model for Noninvasive Prediction of Tumor Mutation Burden and Survival in Locally Advanced Head and Neck Squamous Cell CarcinomaSemantic proximity Read

Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting.Semantic proximity Read